Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
Sonia Serrano, Ramin Massoumi(Lund University), Matthew A. Gregory, Giuseppe Mazza(Cereal Research Centre), Krista Rombouts(University College London), Alvar Grönberg(NeuroVive Pharmaceutical (Sweden)), Steven J. Moss, Philippe Gallay(Scripps Research Institute), Massimo Pinzani(The Royal Free Hospital), Eskil Elmér(Medicon Village), Lisa Longato(University College London), Joseph Kuo(Scripps Research Institute), Magnus J. Hansson(Medicon Village)
Cited by 21
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis†
|Hepatology|2008|420
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation
|Scientific Reports|2015|409